Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
Abroad (travel likely)Recruiting
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Dysbiosis
Locations
- Service de Pneumologie - CHU de Strasbourg - France, Strasbourg, France